PRA Health Sciences: Q2 Earnings Insights


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Shares of PRA Health Sciences (NASDAQ:PRAH) rose 1.24% in after-market trading after the company reported Q2 results.

Quarterly Results

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Earnings per share decreased 29.51% year over year to $0.86, which beat the estimate of $0.82.

Revenue of $729,891,000 decreased by 4.38% from the same period last year, which beat the estimate of $716,720,000.

Guidance

PRA Health Sciences Lowers FY2020 Adj EPS Guidance from $5.77-5.97 to $4.35-4.55 vs $4.31 Est; Lowers FY2020 Sales Guidance from $3.23B-3.36B to $3.07B-3.13B vs $3.07B Est

Technicals

52-week high: $113.31

52-week low: $58.67

Price action over last quarter: Up 25.57%

Company Overview

PRA Health Sciences is a global contract research organization that provides drug development and clinical trial services to pharmaceutical and biotechnology firms. Its services run from early- to late-stage clinical trial outsourcing with varying levels of support, including one-off specialized staffing services to strategic partnerships where PRA handles nearly all aspects of the trial. In 2017, PRA acquired Symphony Health, a healthcare data and analytics provider.


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: Earnings